October 28, 2014 6:17 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Novartis AG (NYSE: NVS) reported a rise in its third-quarter profit.The company's net profit attributable to shareholders climbed 44% to $3.22 billion, versus a year-ago profit of $2.23 billion.Its earnings, excluding some items, rose 9% to $3.35 billion, or $1.37 per share, compared to $3.06 billion, or $1.24 per share, in the year-ago period. However, analysts were expecting a profit of $1.29 per share.Its sales rose 4% to $14.7 billion, versus analysts' estimates of $14.34 billion.Pharmaceuticals net sales were USD 7.9 billion, while Alcon net sales rose to USD 2.7 billion. Sandoz net sales climbed to USD 2.4 billion in the quarter.Free cash flow declined 9% to USD 3.2 billion.Its core margin widened by 1.5 percentage points.Joseph Jimenez, CEO of Novartis, said, “Novartis delivered a very strong third quarter. We delivered solid sales growth with margin expansion. At the same time, we reached key innovation milestones, particularly with LCZ696 in heart failure and AIN457 in psoriasis, underlining the innovation power of the company.”Novartis confirmed its forecast for 2014.Novartis shares rose 2.30% to $92.22 in pre-market trading.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.